Active Pharmaceutical Ingredients

Summary

The bill defines active pharmaceutical ingredients (APIs) and sets detailed requirements for pharmacies and other entities that sell, transfer, or distribute compounded drugs using those ingredients. It mandates compliance with USP/NF monographs or FDA‑approved lists, certification, testing, and recent FDA inspection of the manufacturing facility, plus record‑keeping and board inspections. Violations would incur a $1,000 fine per dose and possible license revocation.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share